Olanzapine may increase the risk of death in older adults with psychosis (loss of touch with reality) related to dementia. Olanzapine is not approved for use in this group of people. For more ...

Please provide your email address to receive an email when new articles are posted on . Low-dose olanzapine appeared noninferior to standard dose for controlling chemotherapy-induced nausea and ...

The addition of olanzapine (Zyprexa) to standard antiemetic therapy among patients receiving highly emetogenic chemotherapy provides better nausea and vomiting relief across subgroups at high risk for ...

Please provide your email address to receive an email when new articles are posted on . A greater proportion of patients assigned olanzapine experienced weight gain compared with the placebo group (60 ...

Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient This investigator-initiated, ...

Schizophrenia and bipolar I disorder are two conditions that have many differences between them. A class of medicines called antipsychotics can be used to treat both conditions but may cause unwanted ...

Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with olanzapine LAI (TEV-'749) and its long-term systemic ...

Teva Pharmaceutical Industries Limited TEVA announced that it has submitted a new drug application (NDA) to the FDA seeking approval for olanzapine, a long-acting subcutaneous injectable (LAI) for ...